CIS: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in CIS

The CIS medicaments containing hormones market expanded modestly to $X in 2023, picking up by X% against the previous year. The total consumption indicated prominent growth from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, consumption decreased by X% against 2021 indices. The level of consumption peaked at $X in 2016; however, from 2017 to 2023, consumption remained at a lower figure.

Medicaments Containing Hormones Production in CIS

In value terms, medicaments containing hormones production expanded significantly to $X in 2023 estimated in export price. The total production indicated a prominent increase from 2012 to 2023: its value increased at an average annual rate of X% over the last eleven-year period. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2023 figures, production decreased by X% against 2021 indices. The pace of growth appeared the most rapid in 2015 when the production volume increased by X% against the previous year. The level of production peaked at $X in 2016; however, from 2017 to 2023, production failed to regain momentum.

Join Us at HANNOVER MESSE 2024

Don’t miss your chance to connect with us directly. Schedule a personal meeting to dive deeper into how solutions.
Hall 002, Stand C10. 22 - 26 April 2024 | Hannover, Germany

Book Your Meeting

Medicaments Containing Hormones Exports

Exports in CIS

In 2023, shipments abroad of medicaments containing hormones but not antibiotics decreased by X% to X kg for the first time since 2020, thus ending a two-year rising trend. In general, exports, however, continue to indicate buoyant growth. The growth pace was the most rapid in 2014 when exports increased by X% against the previous year. The volume of export peaked at X tons in 2022, and then shrank dramatically in the following year.

In value terms, medicaments containing hormones exports declined rapidly to $X in 2023. Overall, exports, however, continue to indicate a significant increase. The pace of growth was the most pronounced in 2014 with an increase of X%. As a result, the exports attained the peak of $X. From 2015 to 2023, the growth of the exports remained at a lower figure.

Exports by Country

Belarus was the key exporter of medicaments containing hormones but not antibiotics in the CIS, with the volume of exports recording X kg, which was near X% of total exports in 2023. It was distantly followed by Russia (X kg), constituting a X% share of total exports.

Belarus was also the fastest-growing in terms of the medicaments containing hormones but not antibiotics exports, with a CAGR of X% from 2012 to 2023. At the same time, Russia (X%) displayed positive paces of growth. While the share of Belarus (X p.p.) increased significantly in terms of the total exports from 2012-2023, the share of Russia (X p.p.) displayed negative dynamics.

In value terms, Belarus ($X) remains the largest medicaments containing hormones supplier in the CIS, comprising X% of total exports. The second position in the ranking was held by Russia ($X), with an X% share of total exports.

In Belarus, medicaments containing hormones exports expanded at an average annual rate of X% over the period from 2012-2023.

Export Prices by Country

The export price in the CIS stood at $X per ton in 2023, rising by X% against the previous year. Overall, the export price posted a measured increase. The most prominent rate of growth was recorded in 2014 an increase of X%. As a result, the export price reached the peak level of $X per ton. From 2015 to 2023, the export prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top suppliers, the country with the highest price was Belarus ($X per ton), while Russia stood at $X per ton.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Belarus (X%).

Medicaments Containing Hormones Imports

Imports in CIS

In 2023, the amount of medicaments containing hormones but not antibiotics imported in the CIS skyrocketed to X tons, picking up by X% compared with 2022 figures. Over the period under review, imports continue to indicate a perceptible increase. As a result, imports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing hormones imports skyrocketed to $X in 2023. In general, imports recorded a prominent expansion. The most prominent rate of growth was recorded in 2019 with an increase of X%. As a result, imports attained the peak of $X. From 2020 to 2023, the growth of imports failed to regain momentum.

Imports by Country

In 2023, Russia (X tons) represented the main importer of medicaments containing hormones but not antibiotics, generating X% of total imports. It was distantly followed by Uzbekistan (X tons), mixing up a X% share of total imports. Tajikistan (X tons) and Belarus (X tons) followed a long way behind the leaders.

From 2012 to 2023, average annual rates of growth with regard to medicaments containing hormones imports into Russia stood at X%. At the same time, Belarus (X%) displayed positive paces of growth. Moreover, Belarus emerged as the fastest-growing importer imported in the CIS, with a CAGR of X% from 2012-2023. Uzbekistan experienced a relatively flat trend pattern. By contrast, Tajikistan (X%) illustrated a downward trend over the same period. While the share of Russia (X p.p.) increased significantly in terms of the total imports from 2012-2023, the share of Uzbekistan (X p.p.) and Tajikistan (X p.p.) displayed negative dynamics. The shares of the other countries remained relatively stable throughout the analyzed period.

In value terms, Russia ($X) constitutes the largest market for imported medicaments containing hormones but not antibiotics in the CIS, comprising X% of total imports. The second position in the ranking was held by Uzbekistan ($X), with a X% share of total imports. It was followed by Belarus, with a X% share.

In Russia, medicaments containing hormones imports increased at an average annual rate of X% over the period from 2012-2023. In the other countries, the average annual rates were as follows: Uzbekistan (X% per year) and Belarus (X% per year).

Import Prices by Country

The import price in the CIS stood at $X per ton in 2023, surging by X% against the previous year. In general, the import price saw a buoyant expansion. The pace of growth was the most pronounced in 2019 an increase of X%. The level of import peaked at $X,722 per ton in 2020; however, from 2021 to 2023, import prices stood at a somewhat lower figure.

Prices varied noticeably by country of destination: amid the top importers, the country with the highest price was Russia ($X per ton), while Tajikistan ($X per ton) was amongst the lowest.

From 2012 to 2023, the most notable rate of growth in terms of prices was attained by Russia (X%), while the other leaders experienced mixed trends in the import price figures.

Source: IndexBox Platform